# A Plaque Test Study With LEO 35299 in Psoriasis Vulgaris

> **NCT01580488** · PHASE1 · COMPLETED · sponsor: **LEO Pharma** · enrollment: 24 (actual)

## Conditions studied

- Psoriasis Vulgaris

## Interventions

- **DRUG:** B LEO 35299 20 mg/g cream
- **DRUG:** C LEO 35299 20 mg/g cream
- **DRUG:** E LEO 35299 10 mg/g solution
- **DRUG:** F LEO 35299 10 mg/g solution
- **DRUG:** Daivonex® ointment
- **DRUG:** Daivonex® ointment vehicle

## Key facts

- **NCT ID:** NCT01580488
- **Lead sponsor:** LEO Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-04
- **Primary completion:** 2012-06
- **Final completion:** 2012-06
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2025-03-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01580488

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01580488, "A Plaque Test Study With LEO 35299 in Psoriasis Vulgaris". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT01580488. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*